BioAge Labs, Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | -19.8% | +204.4% | +120.2% | +2.0% | -98.6% | +25.6% | +3.1% | +27.5% | |
| – | +3.2% | -31.1% | -25.3% | +44.7% | -50.9% | +18.7% | +131.4% | +67.5% | |
| – | -156.3% | – | – | +260.0% | -95.5% | +744.0% | +66.6% | -205.8% | |
| – | -100.0% | – | – | – | – | +61.2% | +120.5% | +96.4% | |
| – | – | – | – | – | – | +158.3% | +37.6% | +25,915.3% | |
| – | -39.0% | -86.3% | +131.7% | -71.3% | – | – | – | – | |
| – | – | – | – | – | – | +1,300.0% | -117.1% | +0.0% | |
| – | -21.3% | -30.2% | -14.0% | -60.1% | -86.7% | +1,298.2% | +991.0% | -97.0% | |
| – | -155.7% | – | – | -225.5% | – | – | – | -150.2% | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.